The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study

BACKGROUND: Bronchiolitis obliterans syndrome (BOS) after allo-HSCT is a devastating complication with limited therapeutic options. We aimed to assess the efficacy and safety of mesenchymal stem cells (MSCs) in BOS after allo-HSCT. METHODS: This multicenter prospective cohort study enrolled 81 allo-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shan, Zhao, Ke, Lin, Ren, Wang, Shunqing, Fan, Zhiping, Huang, Fen, Chen, Xiaoyong, Nie, Danian, Du, Xin, Guo, Ziwen, Lin, Dongjun, Xuan, Li, Xu, Na, Sun, Jing, Peng Xiang, Andy, Liu, Qifa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945279/
https://www.ncbi.nlm.nih.gov/pubmed/31668569
http://dx.doi.org/10.1016/j.ebiom.2019.09.039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945279/
https://www.ncbi.nlm.nih.gov/pubmed/31668569
http://dx.doi.org/10.1016/j.ebiom.2019.09.039

Ejemplares similares